News

AVEREL: Avastin Defers Progression in HER2-Positive Metastatic Breast Cancer*


 

FROM THE SAN ANTONIO BREAST CANCER SYMPOSIUM

*Correction, 12/9/11: An earlier version of this article incorrectly noted in the headline that Avastin improves breast cancer survival.

Pages

Recommended Reading

FDA Revokes Avastin Approval for Breast Cancer
Breast Cancer ICYMI
Practice Changers Expected at San Antonio Breast Cancer Symposium
Breast Cancer ICYMI
BOLERO-2: Everolimus Plus Exemestane Delays Breast Cancer Progression
Breast Cancer ICYMI
Breast Cancer Gene Profile Identifies Early vs. Late Recurrences
Breast Cancer ICYMI
Zoledronic Acid's Breast Cancer Benefit Extends 7 Years
Breast Cancer ICYMI
IOM Dissects Environmental Risk Factors for Breast Cancer
Breast Cancer ICYMI
Dual HER2 Blockade Defers Breast Cancer Progression
Breast Cancer ICYMI
DCIS Assay Predicts Recurrence Risk After Breast Surgery
Breast Cancer ICYMI
Clodronate Offered Modest Benefit for Breast Cancer Patients
Breast Cancer ICYMI
ZO-FAST: Immediate Zoledronic Acid Beats Delayed Tx in Early Breast Cancer
Breast Cancer ICYMI